weeks were included. A receiver operator characteristics (ROC) curve was generated to assess the relationship between A1c and GDM. An ideal cutpoint for early HbA1c was calculated from the ROC curve using the Liu method, and the test characteristics of HbA1c determined. Association of HbA1c above and below the cutpoint with a composite primary outcome of macrosomia (EFW>4000), primary cesarean, shoulder dystocia, pregnancy induced hypertension, hyperbilirubinemia, and hypoglycemia was assessed with a chi squared test. RESULTS: Of 954 women included in the RCT, 501 (52.5%) were included in this analysis. The average GA at HbA1c was 17.5AE1.7, and the average HbA1c at this GA was 5.3AE0.5. The GA at repeat testing was 26.3AE1.4, and 51 women (10.2%) were diagnosed with GDM at 24-28 wks. The ROC curve had an area under the curve (AUC) of 0.63, demonstrating moderate association between early HbA1c and a diagnosis of GDM. At the selected cutoff of 5.4, sensitivity and specificity were both poor (60.8% and 60%, respectively). HbA1c greater than the cutpoint was also not associated with the primary adverse composite outcome (62.6% vs 57.2%, p¼0.23). CONCLUSION: HbA1c for early screening for GDM in obese women performs poorly and should not be used for this purpose.
Fetal cardiomyopathy in diabetic stillbirths
Elizabeth A. Westen, Tara A. Lynch, Arti Taggar, Philip J. Katzman, Amol K. Malshe, Kathryn Drennan University of Rochester Medical Center, Rochester, NY OBJECTIVE: Diabetes in pregnancy is associated with an increased rate of stillbirth. There are a wide variety of factors that have been implicated including placental insufficiency, hypoxia, hyperinsulinemia and impaired cardiac function. There is evidence that diabetic pregnancies have an increased rate of fetal cardiomyopathy (FCM) as compared to non-diabetic pregnancies. The purpose of this study was to determine if diabetic women have an increased rate of FCM identified on fetal autopsy as compared to non-diabetic women with a stillbirth. STUDY DESIGN: Retrospective cohort study of women with a stillbirth who consented to fetal autopsy at an academic medical center from 2011-2017. Stillbirth was defined as an intrauterine fetal demise at !20w gestation. Women with diabetes were compared to women without diabetes. Primary outcome was FCM. Other etiologies for fetal demise were also analyzed. Univariate analysis was performed with p<0.05 considered significant. RESULTS: Of 279 women with stillbirths, 78 elected to have fetal autopsy examinations (27.9%) and 75 had complete information available for review. A total of 60 women did not have diabetes and 15 women had diabetes. Of women with diabetes, 11 had insulin dependent diabetes and 4 had non-insulin dependent diabetes. FCM was diagnosed on autopsy for 46.7% of pregnancies with diabetes and 3.3% of pregnancies without diabetes .47], p<0.001). In those women with insulin dependent diabetes, a total of 54.5% had FCM as compared 4.7% of those not requiring insulin or who were non-diabetic (RR 2.77 [95% CI 1.1-7.0], p<0.001). These associations were significant even when analyzing only those pregnancies without fetal congenital heart disease (diabetic with FCM 46.7% versus nondiabetic with FCM 2.0%, RR 6.90 [95% CI 1.10-43.26], p<0.001). There was no difference between diabetic and non-diabetic pregnancies in regards to other causes for stillbirth. (Table 1) . CONCLUSION: Fetal cardiomyopathy is identified as an etiology for stillbirth more often in pregnancies complicated by diabetes as compared to pregnancies without diabetes. As the prediction and prevention of diabetic stillbirth is limited, information on potential causes may help guide future research to identify those pregnancies at the greatest risk for poor outcome. OBJECTIVE: Childhood obesity is a growing epidemic; nutritional environment before birth and in early infancy may determine later metabolic health. Infants of mothers with gestational diabetes (GDM) have a higher risk for childhood obesity and metabolic syndrome. Leptin and adiponectin are known biomarkers for metabolic syndrome in adults and may be useful to guide interventions to reduce later obesity. We sought to examine relationship between birthweight, early infancy feeding practices and biomarkers for metabolic syndrome in offspring of women with mild GDM. STUDY DESIGN: Secondary analysis of a multicenter randomized treatment trial of women with mild GDM (an abnormal result on an oral glucose-tolerance test with fasting glucose level below 95 mg/dl). The children of these women were evaluated by trained research coordinators and biospecimen obtained at 5-10 years of age. Plasma 
